Atrys Health SA
F:A2T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
Schrodinger Inc
NASDAQ:SDGR
|
US |
|
Coinshares International Ltd
STO:CS
|
JE |
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
E
|
Eaton Corporation PLC
XMUN:3EC
|
IE |
|
I
|
Inchcape PLC
DUS:IJCA
|
UK |
|
C
|
Commonwealth Bank of Australia
F:CWW
|
AU |
Wall St Price Targets
A2T Price Targets Summary
Atrys Health SA
According to Wall Street analysts, the average 1-year price target for A2T is 6.29 EUR with a low forecast of 5.16 EUR and a high forecast of 7.37 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A2T's stock price target?
Price Target
6.29
EUR
According to Wall Street analysts, the average 1-year price target for A2T is 6.29 EUR with a low forecast of 5.16 EUR and a high forecast of 7.37 EUR.
What is the Revenue forecast for Atrys Health SA?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 46%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Atrys Health SA?
Projected CAGR
30%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 34%. The projected CAGR for the next 3 years is 30%.
